HCP-09 BENEFITS OF A NEURO-ONCOLOGY NURSE PROGRAM

Por Daly, Emma, O'Connor, Gabrielle, Todorovic, Lauren, Freilich, Ron
Publicado no Neuro Oncol (2015)

Burden of unique and low prevalence somatic mutations correlates with cancer survival

Por Klebanov, Nikolai, Artomov, Mykyta, Goggins, William B., Daly, Emma, Daly, Mark J., Tsao, Hensin
Publicado no Sci Rep (2019)

HCP-10 INTEGRATED DISEASE MANAGEMENT FOR NEURO-ONCOLOGY PATIENTS AND THEIR FAMILIES: PUTTING PATIENT CENTRED CARE INTO PRACTICE

Por Daly, Emma, Todorovic, Lauren, McLeod, Jo, Barker, Lauren, Whitman, Victoria, Anthonisz, Brian, Higgins, Rosemary, Freilich, Ron
Publicado no Neuro Oncol (2015)

Base-specific mutational intolerance near splice sites clarifies the role of nonessential splice nucleotides

Por Zhang, Sidi, Samocha, Kaitlin E., Rivas, Manuel A., Karczewski, Konrad J., Daly, Emma, Schmandt, Ben, Neale, Benjamin M., MacArthur, Daniel G., Daly, Mark J.
Publicado no Genome Res (2018)

PROTECTIVE LOW FREQUENCY VARIANTS FOR PREECLAMPSIA IN THE FLT1 GENE IN THE FINNISH POPULATION

Por Lokki, A. Inkeri, Daly, Emma, Triebwasser, Michael, Kurki, Mitja I., Roberson, Elisha D.O., Häppölä, Paavo, Auro, Kirsi, Perola, Markus, Heinonen, Seppo, Kajantie, Eero, Kere, Juha, Kivinen, Katja, Pouta, Anneli, Salmon, Jane E., Meri, Seppo, Daly, Mark, Atkinson, John P., Laivuori, Hannele
Publicado no Hypertension (2017)